Last updated
Fullife Healthcare: Capital Raising
D2C health and wellness startup Fullife Healthcare raised ₹300 Cr to expand wellness portfolio, operates Fast&Up and Chicnutrix brands
Source: Inc42 (India/SEA)
- Who
- Fullife Healthcare · Digital Health · India
- What happened
- D2C health and wellness startup Fullife Healthcare raised ₹300 Cr to expand wellness portfolio, operates Fast&Up and Chicnutrix brands
- When
- 2026-03-25
- Source
- Inc42 (India/SEA)
- So what
- Fullife's raise commits the company to a multi-brand portfolio logic it was not operationally required to execute at scale before.
The leadership read
Fullife's raise commits the company to a multi-brand portfolio logic it was not operationally required to execute at scale before. Running Fast&Up and Chicnutrix as parallel D2C brands, each with distinct consumer demographics, formulation requirements, and channel economics, means the company now has to build shared infrastructure (supply chain, data, performance marketing) that serves divergent product postures simultaneously. That is a different operating problem than a single-brand growth push, and ₹300 Cr creates the obligation to execute it at speed. This is one of 12 capital-raising signals we have tracked across health, wellness, and adjacent categories in the last 90 days. The related set is diffuse, spanning AI infrastructure, aviation finance, and mining, which reflects a broad capital deployment moment rather than a tight category surge. Within the health corridor specifically, 01Health's $15M Series A and GenePlanet's strategic round are the closest comparables, both pointing to sustained investor appetite for consumer and digital health platforms at different stages of maturity. The Fullife round is the largest India D2C health transaction in this window. Across companies reaching this stage of multi-brand D2C scaling in emerging consumer markets, the functional pressure concentrates in three areas: brand portfolio management with channel-level P&L ownership, supply-chain and contract-manufacturing operations capable of serving differentiated SKU architectures, and performance marketing leadership that can allocate efficiently across distinct customer acquisition funnels without cannibalizing brand equity between them.
Market context: Against a Talent Market Index of 95.4 (Cool) (down 5.3 month-on-month), Asia is at rising (+3.1pts) on signal share.
Fullife Healthcare: 0 signals in the last 90 days — below the Digital Health median of 1 across 54 tracked companies.
MitchelLake in this thematic
From the MitchelLake archive
More signals across Digital Health
Capital Raising · Asia
Sahajanand Medical Technologies →Sahajanand Medical Technologies opened its IPO on 15 October 2026 to raise about Rs 475.48 crore, with a price band of Rs 327-344 per share and a 12% grey market premium.
Capital Raising · Asia
Kip Corporation →South Korean medical tourism platform operator Kip Corporation (Ippuda) closed a 1 billion KRW seed round to fund international expansion and an AI-based healthcare data platform.
Capital Raising · Asia
Trident Digital Tech Holdings →Trident Digital Tech Holdings completed a US$15 million equity offering in September 2026, bringing total September financing to approximately US$23 million to fund execution of AI and digital infrastructure strategy.
Capital Raising · Asia
Celebal Technologies →Celebal Technologies raised Rs 50 crore ($5.2M) in strategic debt funding from BlackSoil Capital. Company demonstrates strong financial health with 81% revenue CAGR (FY21-FY26) and 3,000+ workforce including 1,500 Databricks-certified employees.
Capital Raising · Asia
Soundable Health →NAVER D2SF makes follow-on investment in AI-driven health tech startup scaling in U.S. market
Where this lands in our work
- Executive Search →
Capital raised becomes leadership hired — the executive build follows the announcement.
- Executive Search: Asia →
Our Asia practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
